Authors:
BANK S
SNINSKY C
ROBINSON M
KATZ S
SINGLETON J
MINER P
SAFDI M
GALANDIUK S
HANAUER S
VARILEK G
SANDS B
BUCHMAN A
ROGERS V
SALZBERG B
CAI B
ROGGE H
SCHWERTSCHLAG U
Citation: S. Bank et al., SAFETY AND ACTIVITY EVALUATION OF RHIL-11 IN SUBJECTS WITH ACTIVE CROHNS-DISEASE, Gastroenterology, 112(4), 1997, pp. 927-927
Authors:
LEVINE DS
PRUITT R
RIFF D
KOVAL G
SALES D
WRUBLE L
REX D
SALZBERG B
MERRELL D
BERRY W
TORRES E
KOGUT D
RUBIN A
YOUNG D
JOHNSON LK
Citation: Ds. Levine et al., A MULTICENTER, DOUBLE-BLIND DOSE-RESPONSE TRIAL OF COLAZIDE(R) (BALSALAZIDE DISODIUM) AND ASACOL(R) (MESALAMINE) FOR MILD-MODERATELY ACTIVEULCERATIVE-COLITIS, Gastroenterology, 112(4), 1997, pp. 1026-1026
Authors:
PEPPERCORN M
DAS K
ELSON C
GERACI K
ROBINSON M
RUBIN A
SALZBERG B
WRUBLE L
DUBE L
ROUNTREE L
BROUTMAN L
Citation: M. Peppercorn et al., ZILEUTON, A 5-LIPOXYGENASE INHIBITOR, IN THE TREATMENT OF ACTIVE ULCERATIVE-COLITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Gastroenterology, 106(4), 1994, pp. 10000751-10000751